What are the diagnostic criteria and symptoms to watch out for in patients with Brugada syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 11, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Brugada Syndrome: Diagnostic Criteria and Clinical Symptoms

Diagnostic ECG Criteria

The diagnosis of Brugada syndrome requires a Type 1 ECG pattern showing coved ST-segment elevation ≥2 mm in one or more right precordial leads (V1 and/or V2), positioned in the second, third, or fourth intercostal space, occurring either spontaneously or after sodium channel blocker challenge (ajmaline, flecainide, procainamide, or pilsicainide). 1

Key ECG Features to Identify

  • Type 1 Pattern (Diagnostic): Coved rSr' morphology with ST-segment elevation ≥2 mm followed by a negative T-wave in V1-V3 2, 1
  • Type 2 Pattern (Non-diagnostic): "Saddle-back" morphology with high takeoff ST-segment elevation ≥2 mm, remaining ≥1 mm above baseline, followed by positive or biphasic T-wave 2
  • Type 3 Pattern (Non-diagnostic): Either coved or saddleback morphology with J-point elevation ≥2 mm but terminal ST-segment <1 mm 2

Critical Diagnostic Considerations

  • High precordial lead placement (second or third intercostal space) significantly improves detection of Type 1 pattern when standard V1-V2 leads are non-diagnostic 1
  • The ECG pattern is highly dynamic and transient, fluctuating between normal and abnormal over time, requiring serial ECGs for diagnosis 1
  • Only Type 1 pattern is diagnostic; Types 2 and 3 require sodium channel blocker challenge to unmask Type 1 pattern 2

Clinical Symptoms and Warning Signs

Cardinal Symptoms to Monitor

Syncope is the most critical symptom, particularly when occurring:

  • At rest or during sleep (enhanced vagal tone) 1
  • Without clear precipitating factors 3
  • In patients with spontaneous Type 1 ECG pattern (6-fold higher cardiac arrest risk) 1

Sudden cardiac death or aborted cardiac arrest from polymorphic ventricular tachycardia/ventricular fibrillation 3, 4

Additional Clinical Features

  • Seizure-like episodes (actually arrhythmic events misdiagnosed as seizures) 1
  • Unexplained nocturnal agonal respirations (arrhythmias during sleep) 1
  • Palpitations preceding syncope 4
  • Atrial fibrillation (occurs more frequently than in general population) 4

Critical Triggers and Precipitants

Immediate Triggers Requiring Aggressive Management

  • Fever: Most critical trigger for ventricular fibrillation requiring early, aggressive antipyretic treatment 3, 1
  • Vagotonic states: Rest, sleep, post-prandial state 1
  • Electrolyte disturbances: Hyperkalemia, hypercalcemia 2

Medications to Avoid

  • Sodium channel blockers (Class I antiarrhythmics) 3
  • Psychotropic medications (tricyclic antidepressants, phenothiazines) 3
  • Anesthetic agents 3
  • Cocaine 3
  • Excessive alcohol intake 3, 1

Risk Stratification Framework

Highest Risk (Annual Event Rate 13.5%)

  • Cardiac arrest survivors 3
  • Spontaneous Type 1 ECG + syncope (presumed ventricular arrhythmia) 3
  • Spontaneous Type 1 ECG + ≥2 risk factors (syncope, family history of sudden death <50 years, positive electrophysiologic study) 5

Intermediate Risk (Annual Event Rate 3.2%)

  • Syncope with spontaneous Type 1 ECG 3, 1

Lower Risk (Annual Event Rate 1%)

  • Asymptomatic with spontaneous Type 1 ECG 3
  • Drug-induced Type 1 pattern only (very low risk, no chronic therapy needed) 1

Additional ECG Risk Markers

Beyond the Type 1 pattern, the following ECG features indicate increased arrhythmic risk:

  • First-degree AV block (PR interval >200 ms) 4, 6
  • QRS duration ≥120 ms in V2 4, 6
  • Fragmented QRS complex 4, 6
  • S wave in lead I (≥40 ms duration, amplitude ≥0.1 mV, area ≥1 mm²) 6
  • R wave in lead aVR 6
  • Inferior/lateral early repolarization pattern 4, 6
  • T-wave alternans (sign of acute electrical instability) 4, 6

Family History Red Flags

  • Sudden cardiac death in family members <50 years of age 1
  • Unexplained drowning in young family members 1
  • Type 1 ECG pattern in family members 1

Practical Clinical Approach

  1. Confirm Type 1 pattern: Verify correct lead placement, repeat ECG, perform high precordial leads (V1-V2 in 2nd/3rd intercostal space) 1
  2. Obtain detailed history: Personal syncope/seizures, family history of sudden death <50 years, unexplained drowning, exertional syncope 1
  3. Refer to electrophysiologist regardless of symptoms when Type 1 pattern is confirmed 1
  4. Consider sodium channel blocker challenge in patients with suspected Brugada syndrome but no baseline Type 1 pattern 1
  5. Educate patients about arrhythmia triggers, forbidden drugs, and need for aggressive fever treatment 3, 1
  6. Screen first-degree relatives with ECG and consider genetic counseling 3, 1

Common Pitfalls

  • Missing the diagnosis due to transient ECG changes—serial ECGs are essential 1
  • Misdiagnosing as right bundle branch block or early repolarization—use Corrado index and high precordial leads 1
  • Underestimating fever risk—fever is a critical trigger requiring immediate aggressive antipyretic treatment 3
  • Relying solely on genetic testing—SCN5A mutations account for only 20-30% of cases; diagnosis is primarily clinical and electrocardiographic 3, 1

References

Guideline

Management of Brugada Syndrome Based on ECG Findings

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Brugada Syndrome Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Brugada ECG].

Herzschrittmachertherapie & Elektrophysiologie, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.